Trump: Why allow immigrants from ‘shithole countries’

Agencies
January 12, 2018

New Delhi, Jan 12: In bluntly vulgar language, President Donald Trump questioned Thursday why the U.S. would accept more immigrants from Haiti and “shithole countries” in Africa rather than places like Norway, as he rejected a bipartisan immigration deal, according to people briefed on the extraordinary Oval Office conversation.

Trump’s contemptuous description of an entire continent startled lawmakers in the meeting and immediately revived charges that the president is racist, reports AP.  The White House did not deny his remark but issued a statement saying Trump supports immigration policies that welcome “those who can contribute to our society.”

 Trump’s comments came as two senators presented details of a bipartisan compromise that would extend protections against deportation for hundreds of thousands of young immigrants _ and also strengthen border protections as Trump has insisted.

The lawmakers had hoped Trump would back their accord, an agreement among six senators evenly split among Republicans and Democrats, ending a months-long, bitter dispute over protecting the “Dreamers.” But the White House later rejected it, plunging the issue back into uncertainty just eight days before a deadline that threatens a government shutdown.

Dick Durbin of Illinois, the Senate’ s No. 2 Democrat, explained that as part of that deal, a lottery for visas that has benefited people from Africa and other nations would be ended, the sources said, though there could be another way for them to apply. Durbin said people would be allowed to stay in the U.S. who fled here after disasters hit their homes in places including El Salvador, Guatemala and Haiti.

Trump specifically questioned why the U.S. would want to admit more people from Haiti. As for Africa, he asked why more people from “shithole countries” should be allowed into the U.S., the sources said. The president suggested that instead, the U.S. should allow more entrants from countries like Norway. Trump met this week with Norwegian Prime Minister Erna Solberg.

Asked about the remarks, White House spokesman Raj Shah did not deny them. “Certain Washington politicians choose to fight for foreign countries, but President Trump will always fight for the American people,” he said. Trump’s remarks were remarkable even by the standards of a president who has been accused by his foes of racist attitudes and has routinely smashed through public decorum that his modern predecessors have generally embraced.

Trump has claimed without evidence that Barack Obama, the nation’s first black president, wasn’t born in the United States, has said Mexican immigrants were “bringing crime” and were “rapists” and said there were “very fine people on both sides” after violence at a white supremacist rally in Charlottesville, Virginia, left one counter-protester dead.

“Racist,” tweeted Rep. Kathleen Rice, D-N.Y., after Thursday’s story broke. Trump has called himself the “least racist person that you’ve ever met.” Critics also have questioned his mental fitness to serve as president, citing his inability to muster some policy details and his tweets asserting his “nuclear button” is bigger than North Korea’s. He responded to such criticism with a recent tweet calling himself “a very stable genius” who is “like, really smart.”

The sources spoke on condition of anonymity because they weren’t authorized to publicly describe the conversation. One said lawmakers in the room were taken aback by Trump’s remarks. The Trump administration announced late last year that it would end a temporary residency permit program that allowed nearly 60,000 citizens from Haiti to live and work in the United States following a devastating 2010 earthquake.

Trump has spoken positively about Haitians in public. During a 2016 campaign event in Miami, he said “the Haitian people deserve better” and told the audience of Haitian-Americans he wanted to “be your greatest champion, and I will be your champion.” The agreement that Durbin and Sen. Lindsey Graham, R-S.C., described to Trump also includes his $1.6 billion request for a first installment on his long-sought border wall, aides familiar with the agreement said. They required anonymity because the agreement is not yet public.

Trump’s request covers 74 miles of border wall as part of a 10-year, $18 billion proposal. Democrats had long vowed they wouldn’t fund the wall but are accepting the opening request as part of a broader plan that protects from deportation about 800,000 younger immigrants brought to the country as children and now here illegally.

The deal also would include restrictions on a program allowing immigrants to bring some relatives to the U.S. In an afternoon of drama and confusing developments, four other GOP lawmakers _ including hardliners on immigration _ were also in Trump’s office for Thursday’s meeting, a development sources said Durbin and Graham did not expect. It was unclear why the four Republicans were there, and the session did not produce the results the two senators were hoping for.

“There has not been a deal reached yet,” said White House spokeswoman Sarah Huckabee Sanders. But she added, “We feel like we’re close.” Underscoring the hurdles facing the effort, other Republicans also undercut the significance of the deal the half-dozen senators hoped to sell to Trump.

“How do six people bind the other 94 in the Senate? I don’t get that,” said No. 2 Senate Republican John Cornyn of Texas. Cornyn said the six lawmakers were hoping for a deal and “everyone would fall in line. The president made it clear to me on the phone less than an hour ago that he wasn’t going to do that.”

The six senators have been meeting for months to find a way to revive protections for young immigrants who arrived in the U.S. as children and are here illegally. Trump ended the Obama-era Deferred Action for Childhood Arrivals program last year but has given Congress until March 5 to find a way to keep it alive.

Federal agencies will run out of money and have to shut down if lawmakers don’t pass legislation extending their financing by Jan. 19. Some Democrats are threatening to withhold their votes _ which Republicans will need to push that legislation through Congress _ unless an immigration accord is reached. Cornyn said the real work for a bipartisan immigration deal will be achieved by a group of four leading lawmakers _ the No. 2 Republicans and Democrats in both the House and Senate. That group met for the first time this week.

The immigration effort seemed to receive a boost Tuesday when Trump met with two dozen lawmakers and agreed to seek a bipartisan way to resuscitate the program. The group agreed to also include provisions strengthening security _ which for Trump means building parts of a wall along the border with Mexico _ curbing immigrants’ relatives from coming here and restricting the visa lottery.

Also in Thursday’s Oval Office meeting were House Majority Leader Kevin McCarthy, R-Calif., House Judiciary Committee Chairman Bob Goodlatte, R-Va., and GOP Sens. Tom Cotton of Arkansas and David Perdue of Georgia. Aides to lawmakers who attended declined to provide comment on Trump’s remarks.

Any immigration deal would face hurdles winning congressional approval. Many Democrats would oppose providing substantial sums for Trump’s campaign promise to build a wall along the border with Mexico. Many Hispanic and liberal members of the party oppose steps toward curtailing immigration such as ending the visa lottery and restricting the relatives that legal immigrants could bring to the U.S.

Among Republicans, some conservatives are insisting on going further than the steps that Trump has suggested. They want to reduce legal immigration, require employers to verify workers’ citizenship and block federal grants to so-called sanctuary cities that hinder federal anti-immigrant efforts.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

Washington, May 19: As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.

The company is hopeful that it's vaccine could be available to the public as early as January next year. Several firms across the world are in the race to develop a vaccine for the deadly virus which has claimed over 3 lakh lives worldwide.

CNN citing Dr. Tal Zaks, Moderna's chief medical officer reported that "if future studies go well, the company's vaccine could be available to the public as early as January".

"This is absolutely good news and news that we think many have been waiting for for quite some time," Zaks was quoted as saying.

Moderna, based in Cambridge, Massachusetts announced that the vaccine developed neutralising antibodies to the virus at levels reaching or exceeding the levels seen in people who have naturally recovered from Covid-19, reported CNN.

These will be followed by phase 2 trials and phase 3 trials, which Moderna plans to start in July.

President Donald Trump had on Friday said that that the United States will be able to deliver a few hundred million doses of COVID-19 vaccine, under 'Operation Warp Speed', by the end of this year.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020 and we will do the best we can," Trump had said at a press conference at the White House on Friday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 22,2020

Washington, Feb 22: US President Donald Trump will raise the issue of religious freedom with Prime Minister Narendra Modi during his visit to India next week, the White House said on Friday, noting that the US has great respect for India's democratic traditions and institutions.

"President Trump will talk about our shared tradition of democracy and religious freedom both in his public remarks and then certainly in private. He will raise these issues, particularly the religious freedom issue, which is extremely important to this administration," a senior official told reporters in a conference call.

The official was responding to a question on whether the president was planning to speak to Modi on the Citizenship (Amendment) Act or the National Register of Citizens.

"We do have this shared commitment to upholding our universal values, the rule of law. We have great respect for India's democratic traditions and institutions, and we will continue to encourage India to uphold those traditions," the official said, requesting anonymity.

"And we are concerned with some of the issues that you have raised," the senior administration official said, in response to the question on CAA and NRC.

"I think the President will talk about these issues in his meetings with Prime Minister Modi and note that the world is looking to India to continue to uphold its democratic traditions, respect for religious minorities," the official said.

"Of course, it's in the Indian constitution -- religious freedom, respect for religious minorities, and equal treatment of all religions. So this is something that is important to the president and I'm sure it will come up," said the official.

Pointing out that India has a strong democratic foundation, the official said India is a country rich in religious, linguistic, and cultural diversity.

"In fact, it's the birthplace of four major world religions," the official noted.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Russia boasts that it's about to become the first country to approve a Covid-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire.

Moscow sees a Sputnik-like propaganda victory, recalling the Soviet Union's launch of the world's first satellite in 1957.

But the experimental Covid-19 shots began first-in-human testing on a few dozen people less than two months ago, and there's no published scientific evidence yet backing Russia's late entry to the global vaccine race, much less explaining why it should be considered a front-runner.

“I'm worried that Russia is cutting corners so that the vaccine that will come out may be not just ineffective, but also unsafe,” said Lawrence Gostin, a global public health law expert at Georgetown University. “It doesn't work that way... Trials come first. That's really important.”

According to Kirill Dmitriev, head of Russia's Direct Investment Fund that bankrolled the effort, a vaccine developed by the Gamaleya research institute in Moscow may be approved in days, before scientists complete what's called a Phase 3 study.

That final-stage study, usually involving tens of thousands of people, is the only way to prove if an experimental vaccine is safe and really works.

Health Minister Mikhail Murashko said members of “risk groups,” such as medical workers, may be offered the vaccine this month.

He didn't clarify whether they would be part of the Phase 3 study that is said to be completed after the vaccine receives “conditional approval.”

Deputy Prime Minister Tatyana Golikova promised to start “industrial production” in September, and Murashko said mass vaccination may begin as early as October.

Dr Anthony Fauci, the top US infectious disease specialist, questioned the fast-track approach last week.

“I do hope that the Chinese and the Russians are actually testing a vaccine before they are administering the vaccine to anyone, because claims of having a vaccine ready to distribute before you do testing I think is problematic at best," he said.

Questions about this vaccine candidate come after the US, Britain and Canada last month accused Russia of using hackers to steal vaccine research from Western labs.

Delivering a vaccine first is a matter of national prestige for the Kremlin as it tries to assert the image of Russia as a global power capable of competing with the US and China.

The notion of being “the first in the world” dominated state news coverage of the effort, with government officials praising reports of the first-step testing.

In April, President Vladimir Putin ordered state officials to shorten the time of clinical trials for a variety of drugs, including potential coronavirus vaccines.

According to Russia's Association of Clinical Trials Organizations, the order set “an unattainable bar” for scientists who, as a result, "joined in on the mad race, hoping to please those at power.”

The association first raised concern in late May, when professor Alexander Gintsburg, head of the Gamaleya institute, said he and other researchers tried the vaccine on themselves.

The move was a “crude violation of the very foundations of clinical research, Russian law and universally accepted international regulations" the group said in an open letter to the government, urging scientists and health officials to adhere to clinical research standards.

But a month later, the Health Ministry authorized clinical trials of the Gamaleya product, with what appeared to be another ethical issue.

Human studies started June 17 among 76 volunteers. Half were injected with a vaccine in liquid form and the other half with a vaccine that came as soluble powder.

Some in the first half were recruited from the military, which raised concerns that servicemen may have been pressured to participate.

Some experts said their desire to perform well would affect the findings. “It's no coincidence media reports we see about the trials among the military said no one had any side effects, while the (other group) reported some," said Vasily Vlassov, a public health expert with Moscow's Higher School of Economics.

As the trials were declared completed and looming regulatory approval was announced last week, questions arose about the vaccine's safety and effectiveness.

Government assurances the drug produced the desired immune response and caused no significant side effects were hardly convincing without published scientific data describing the findings.

The World Health Organization said all vaccine candidates should go through full stages of testing before being rolled out.

“There are established practices and there are guidelines out,” WHO spokesman Christian Lindmeier said Tuesday.

“Between finding or having a clue of maybe having a vaccine that works, and having gone through all the stages, is a big difference.”

Offering an unsafe compound to medical workers on the front lines of the outbreak could make things worse, Georgetown's Gostin said, adding: “What if the vaccine started killing them or making them very ill?”

Vaccines that are not properly tested can cause harm in many ways — from a negative impact on health to creating a false sense of security or undermining trust in vaccinations, said Thomas Bollyky, director of the global health program at the Council on Foreign Relations. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.